Preventing the next event in the elderly: The PROSPER perspective

Atherosclerosis Supplements

Volumn 4, Issue 5, 2003, Pages 17-22

  Shepherd, James ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Acute coronary syndrome; Elderly; Polypharmacy; Pravastatin; PROSPER

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; PRAVASTATIN; HYPOCHOLESTEROLEMIC AGENT;

CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; HUMAN; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; MUSCLE DISEASE; POLYPHARMACY; PRIORITY JOURNAL; REVIEW; RHABDOMYOLYSIS; RISK REDUCTION; SIDE EFFECT; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; FEMALE; MALE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

AGED; ANTICHOLESTEREMIC AGENTS; CEREBROVASCULAR DISORDERS; CORONARY DISEASE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PRAVASTATIN; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS;

EID: 1442351780     PISSN: 15675688     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5688(03)90003-1     Document Type: Article

References (17)

1. United Nations. World Populations Prospects, Volume II: Sex and Age. New York, NY: United Nations, 1998.
2. United Nations. The Sex and Age Distribution of the World Populations, Volume II: Sex and Age. New York, NY: United Nations, Publication Sales No. E.99.XIII.8.
3. American Heart Association. 2000 Heart and Stroke Statistical Update. Dallas, TX: American Heart Association, 1999.
4. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285(19):2486-97.
5. Shepherd J, Blauw GJ, Murphy MB, et al. The design of a prospective study of pravastatin in the elderly at risk (PROSPER). Am J Cardiol 1999;84:1192-7.
6. Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002;360:1623-30.
7. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Study (4S). Lancet 1994;344(8934):1383-9.
8. Sacks M, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) trial investigators. N Engl J Med 1996;335(14):1001-9.
9. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group. N Engl J Med 1998;339(19):1349-57.
10. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995;333:1301-7.
11. Lewis SJ, Moye LA, Sacks FM, et al. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. Ann Intern Med 1998;129:681-9.
12. White HD, Simes RJ, Anderson NE, et al. Pravastatin therapy and the risk of stroke. N Engl J Med 2000;343:317-26.
13. Aronow WS, Ahn C. Prevalence of coexistence of coronary artery disease, peripheral arterial disease, and atherothrombotic brain infarction in men and women 62 years of age. Am J Cardiol 1994;74:64-5.
14. The PPP Project Investigators. Design, rationale and baseline characteristics of the prospective pravastatin pooling PPP project: a combined analysis of three large scale randomised trials. Am J Cardiol 1995;76:899-905.
15. Byington RP, Davis BR, Plehn JF, et al. Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) project. Circulation 2001;103:387-92.
16. Sacks FM, Tonkin A, Shepherd J, et al. Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling project. Circulation 2000;102:1893-900.
17. Buckley BM. Healthy ageing: ageing safely. J Eur Soc Cardiol 2001;3(N):N6-N10.